Fact-checked by Grok 2 weeks ago

Minimum bactericidal concentration

The minimum bactericidal concentration (MBC) is the lowest concentration of an antimicrobial agent required to kill a specific bacterium under standardized in vitro conditions, typically defined as achieving a 99.9% (3-log) reduction in the viable bacterial population from the initial inoculum.^[1]^[2] This measure assesses the bactericidal (killing) activity of antibiotics, distinguishing them from bacteriostatic agents that merely inhibit growth, and is particularly relevant for treating severe infections where complete eradication of pathogens is essential.^[3]^[2] MBC testing is typically performed following determination of the minimum inhibitory concentration (MIC), the lowest concentration that prevents visible bacterial growth.^[1] In the standard broth dilution method, serial dilutions of the antimicrobial are inoculated with a standardized bacterial suspension (e.g., 10^5 to 10^6 CFU/mL) and incubated for 18–24 hours; samples from tubes showing no growth (at or above the MIC) are then subcultured onto agar plates to check for viability, with the MBC identified as the lowest concentration yielding no or minimal colony growth after further incubation.^[1]^[2] Antibiotics are considered bactericidal if the MBC is no more than four times the MIC (MBC/MIC ratio ≤ 4), though this ratio can vary by organism, agent, and growth conditions such as planktonic versus biofilm states.^[2]^[3] In clinical microbiology, MBC values guide antimicrobial selection for infections like endocarditis or those involving biofilms, where higher concentrations may be needed to eradicate persistent bacteria (e.g., MBC for biofilm cells can be 10–100 times higher than for planktonic cells).^[3]^[2] Although not routinely performed due to technical demands and lack of standardized breakpoints in guidelines like those from the Clinical and Laboratory Standards Institute (CLSI), MBC testing remains valuable for research, antimicrobial development, and evaluating resistance mechanisms.^[4]^[2]

Definition and Concepts

Definition

The minimum bactericidal concentration (MBC) is defined as the lowest concentration of an antimicrobial agent required to kill 99.9% (a 3-log reduction) of the initial bacterial inoculum of approximately 5 × 10^5 colony-forming units per milliliter under standardized in vitro conditions, typically after 18-24 hours of incubation.^[5] This threshold represents a significant reduction in viable bacteria, distinguishing bactericidal activity from mere inhibition of growth.^[3] Bactericidal action, as assessed by MBC, involves the complete elimination of viable bacteria such that no regrowth occurs upon subculture onto nutrient-rich agar plates free of the antimicrobial agent.^[6] This measurement confirms the agent's capacity to eradicate the bacterial population rather than merely suppressing replication, providing a key endpoint for evaluating antimicrobial potency.^[4] MBC values are conventionally expressed in micrograms per milliliter (μg/mL) or milligrams per liter (mg/L), aligning with standard units for antimicrobial concentrations in susceptibility testing.^[1]

Relation to Minimum Inhibitory Concentration

The minimum inhibitory concentration (MIC) represents the lowest concentration of an antimicrobial agent that prevents visible growth (turbidity) of a bacterial inoculum after overnight incubation, primarily reflecting bacteriostatic effects by halting multiplication without eradicating the population.^[4]^[7] In contrast, the minimum bactericidal concentration (MBC) measures the endpoint of actual bacterial killing, typically defined as a 99.9% reduction in viable cells. This conceptual distinction underscores their complementary roles: MIC evaluates suppression of growth, while MBC assesses lethality, allowing for a fuller characterization of an agent's pharmacodynamic profile. The ratio of MBC to MIC provides a key metric for classifying antimicrobial activity. Generally, a ratio of ≤ 4 indicates bactericidal action, while a ratio > 4 indicates bacteriostatic activity, though some agents may exhibit concentration-dependent killing requiring higher concentrations for bactericidal effects.^[8] For instance, beta-lactams like penicillins often display low MBC/MIC ratios (typically ≤4), enabling rapid bactericidal activity through cell wall disruption even at concentrations close to the MIC.^[9] Conversely, tetracyclines exhibit high ratios (>16), aligning with their bacteriostatic mechanism of protein synthesis inhibition that spares bacterial survival at sublethal levels.^[10] MIC is routinely determined in standardized in vitro antimicrobial susceptibility testing protocols, such as those from the Clinical and Laboratory Standards Institute (CLSI), with MBC often assessed additionally for agents used in treating severe infections where rapid eradication is critical.^[11] This assessment informs whether an antimicrobial relies on host immunity for clearance (bacteriostatic) or can independently resolve infections (bactericidal).

Determination Methods

Laboratory Techniques

The determination of the minimum bactericidal concentration (MBC) in laboratory settings primarily relies on standardized dilution methods that extend from minimum inhibitory concentration (MIC) testing, often using the same setup for efficiency.^[12] These techniques assess the lowest antimicrobial concentration that reduces the viable bacterial population by at least 99.9% (a 3-log reduction) relative to the initial inoculum after incubation. Common media include cation-adjusted Mueller-Hinton broth (CAMHB) or agar (CAMHA), with a standardized inoculum of approximately 5 × 10^5 colony-forming units per milliliter (CFU/mL) prepared from a 0.5 McFarland turbidity standard.^[12]^[13] In the broth microdilution method, serial two-fold dilutions of the antimicrobial agent are prepared in CAMHB within a 96-well microtiter plate, typically ranging from high to subinhibitory concentrations.^[12] The standardized bacterial inoculum is added to each well, achieving a final density of 5 × 10^5 CFU/mL, and the plate is incubated aerobically at 35 ± 2°C for 18–24 hours.^[13] Following incubation, wells showing no visible growth (indicating potential MIC values) are identified, and 10 μL aliquots from these clear wells are subcultured onto antimicrobial-free CAMHA plates.^[12] The plates are then incubated under the same conditions, and growth is assessed; the MBC is defined as the lowest concentration yielding fewer than 5 colonies per subculture (corresponding to <0.1% survivors of the original inoculum). This method allows high-throughput testing and is recommended by CLSI guidelines for its reproducibility.^[12] The agar dilution method involves incorporating serial two-fold dilutions of the antimicrobial directly into molten CAMHA, which is then poured into Petri dishes to create plates with varying concentrations.^[13] A standardized inoculum, adjusted to deliver approximately 10^4 CFU per spot (from a 0.5 McFarland suspension diluted 1:10), is applied as multiple 1–5 μL spots or a lawn streak onto each plate using a replicator or multipoint inoculator.^[12] The plates are incubated aerobically at 35 ± 2°C for 16–20 hours, after which growth inhibition is observed.^[13] For MBC assessment, areas of no growth are subcultured or directly evaluated for residual viable CFU by plating dilutions; the MBC is the lowest concentration preventing colony formation, indicating a 99.9% reduction in viable cells.^[12] This technique is useful for testing multiple isolates simultaneously but requires more media preparation. As an alternative, time-kill assays provide dynamic insights into bactericidal activity by monitoring viable counts over time rather than at a single endpoint.^[12] CAMHB tubes containing serial antimicrobial dilutions are inoculated to a starting density of 5 × 10^5 CFU/mL and incubated at 35 ± 2°C with shaking.^[12] Samples are withdrawn at intervals (e.g., 0, 4, 6, 8, 12, and 24 hours), serially diluted in saline, and plated on CAMHA to enumerate CFU/mL after overnight incubation.^[12] Viable counts are plotted as log10 CFU/mL versus time, and the MBC is determined as the lowest concentration achieving a ≥3-log10 reduction (99.9% kill) from the initial inoculum by 24 hours, compared to the untreated control. This method is particularly valuable for evaluating concentration-dependent killing kinetics.^[12]

Interpretation of Results

The interpretation of minimum bactericidal concentration (MBC) results involves assessing the ratio of MBC to minimum inhibitory concentration (MIC) to classify antimicrobial activity as bactericidal or bacteriostatic. For most pathogens, an antimicrobial is considered bactericidal if the MBC is less than or equal to four times the MIC (MBC/MIC ≤ 4), indicating effective killing of ≥99.9% of the bacterial inoculum under standard conditions.^[14] If the MBC exceeds four times the MIC (MBC/MIC > 4), the agent is typically classified as bacteriostatic, relying primarily on growth inhibition rather than direct killing.^[15] This threshold provides a practical framework for evaluating antimicrobial potency, though it is a conventional guideline rather than a strict regulatory breakpoint. Exceptions to this threshold apply to slow-growing organisms, such as Mycobacterium species, where higher MBC/MIC ratios (>4) are common due to their reduced metabolic rates and persistence mechanisms, often resulting in bacteriostatic rather than bactericidal effects even at elevated concentrations.^[16] In susceptibility reports, MBC values are routinely presented alongside MIC results to inform therapeutic choices, with interpretations guided by breakpoints from organizations like the Clinical and Laboratory Standards Institute (CLSI) or the European Committee on Antimicrobial Susceptibility Testing (EUCAST), which primarily standardize MIC categories (susceptible, intermediate, resistant) but support MBC as a supplementary metric for cidal activity assessment.^[17] Statistical evaluation of MBC data emphasizes reproducibility, with acceptable intra-laboratory variation typically limited to less than two twofold dilutions to ensure reliable results across repeated tests. Quality control strains, such as Escherichia coli ATCC 25922, are essential for validating assay performance, providing expected MIC ranges (e.g., 4–16 mg/L for amoxicillin-clavulanate) to confirm method accuracy and detect procedural deviations.^[18] Inter-laboratory comparisons may show slightly wider variation, underscoring the need for standardized protocols like broth microdilution to minimize discrepancies. Common sources of error in MBC interpretation include underestimation of the MBC due to viable but non-culturable cells that fail to grow on subculture plates, leading to an apparently lower MBC value as they are mistaken for dead cells. Conversely, underestimation can occur if resistant subpopulations within the inoculum are overlooked, leading to an erroneously low MBC that fails to account for the full spectrum of tolerance and potentially misleading clinical predictions of efficacy.^[19] These issues highlight the importance of rigorous inoculum preparation and multiple subcultures from MIC wells to accurately reflect bactericidal potential.

Applications and Significance

In Antimicrobial Susceptibility Testing

In antimicrobial susceptibility testing (AST), the minimum bactericidal concentration (MBC) plays a supplemental role within established frameworks to assess bactericidal efficacy beyond minimum inhibitory concentration (MIC) determinations. The Clinical and Laboratory Standards Institute (CLSI) document M26 outlines standardized methods for evaluating bactericidal activity, including MBC testing via time-kill curves and subculture from dilution assays, particularly recommended for select clinical scenarios such as infective endocarditis or infections in neutropenic patients where rapid bacterial killing is essential due to impaired host defenses.^[20] These approaches ensure that AST profiles distinguish between bacteriostatic and bactericidal effects in high-stakes infections. MBC testing is not routinely incorporated into standard AST protocols owing to its technical demands, which involve additional subculturing steps from MIC wells or plates to quantify ≥99.9% bacterial kill, increasing labor and turnaround time compared to MIC alone.^[20] Instead, it serves as a targeted supplemental tool, especially for validating novel antimicrobials during preclinical and regulatory evaluation, where demonstrating bactericidal potential against key pathogens informs dosing and safety profiles as per guidelines from the European Medicines Agency (EMA) and U.S. Food and Drug Administration (FDA). The MBC/MIC ratio acts as a primary interpretive metric, with values ≤4 typically signifying bactericidal activity. For example, in evaluating beta-lactams against Staphylococcus aureus, MBC testing reveals low ratios (often ≤4) for susceptible strains, confirming reliable bactericidal efficacy essential for treating severe infections like bacteremia.^[21] Automation trends facilitate partial integration of MBC into workflows; E-test strips enable precise MIC gradients on agar, allowing approximation of MBC through targeted subculture from inhibition zones, while systems like VITEK 2 provide rapid MIC results that can prompt manual MBC follow-up when needed.^[22]

In Clinical Decision-Making

In clinical decision-making, the minimum bactericidal concentration (MBC) guides the selection of antibiotics for severe infections where rapid bacterial eradication is critical to prevent complications such as sepsis or organ failure. Agents with low MBC values are prioritized to ensure bactericidal activity, particularly in immunocompromised patients or those with endovascular infections. For instance, aminoglycosides like gentamicin are preferred for Gram-negative bacteremia due to their concentration-dependent killing and typically low MBC/MIC ratios (≤4), which facilitate swift pathogen clearance and reduce mortality risk.^[23]^[24] High MBC/MIC ratios, indicating bacterial tolerance to monotherapy, often prompt the use of combination regimens to achieve synergistic bactericidal effects. In prosthetic valve endocarditis caused by staphylococci, vancomycin alone may exhibit elevated MBC values, leading clinicians to add rifampin for enhanced intracellular penetration and overall killing efficacy, as recommended in standard guidelines.^[25]^[26] Pharmacokinetic/pharmacodynamic (PK/PD) considerations integrate MBC data to optimize dosing, ensuring serum concentrations exceed the MBC for optimal therapeutic response. For time-dependent killers like beta-lactams, targets include maintaining free drug levels above 4-5 times the MIC for 40-50% of the dosing interval to maximize bactericidal activity in severe cases.^[27] In endocarditis, serum bactericidal titers (SBT) are monitored, with peak values ≥1:8 to 1:16 correlating with improved outcomes by confirming bactericidal exposure.^[27] Studies, including meta-analyses, support the use of bactericidal agents (low MBC) in specific infections like endocarditis, where they are associated with superior sterilization of vegetations and reduced relapse compared to bacteriostatic options, despite no broad mortality differences across all serious infections.^[28]^[29]

Influencing Factors and Limitations

Biological and Environmental Variables

The minimum bactericidal concentration (MBC) of antibiotics varies significantly due to intrinsic bacterial characteristics. Different bacterial species exhibit distinct MBC values influenced by their physiological traits, such as membrane composition and resistance mechanisms. For instance, Pseudomonas aeruginosa often displays higher MBCs compared to Streptococcus species against certain antibiotics, primarily due to the presence of efflux pumps like MexAB-OprM that actively expel antimicrobial agents from the cell. These pumps contribute to intrinsic resistance, requiring higher concentrations to achieve bactericidal effects in gram-negative pathogens like P. aeruginosa.^[30] The size of the bacterial inoculum also profoundly impacts MBC determinations through the inoculum effect, where larger initial bacterial densities lead to elevated MBC values. This phenomenon arises because higher inocula accelerate the transition to stationary growth phase, reducing antibiotic efficacy, particularly for time-dependent agents like beta-lactams.^[31] In such scenarios, the effective drug concentration available for killing diminishes, necessitating up to several-fold higher doses to eradicate 99.9% of the population.^[32] Environmental and host-related factors further modulate MBC by altering antibiotic activity in physiological contexts. Variations in pH can significantly affect MBC; for example, acidic conditions increase the MBC of macrolides like erythromycin by impairing their ionization and uptake into bacterial cells.^[33] Oxygen levels influence MBC through their role in bacterial respiration, as many antibiotics, including aminoglycosides and fluoroquinolones, rely on active metabolism for bactericidal action, leading to higher MBCs under anaerobic conditions.^[34] Similarly, serum proteins bind to antibiotics, reducing the free fraction available for bacterial killing and thereby elevating MBC values, an effect pronounced for highly protein-bound agents like clindamycin.^[35] Interactions between antimicrobials can lower MBC through synergistic effects. Combinations of beta-lactams and aminoglycosides often exhibit synergy, reducing the MBC of each drug by facilitating enhanced bacterial uptake or membrane permeabilization, as observed in P. aeruginosa isolates where such pairs achieve bactericidal activity at concentrations below individual MBCs.^[36] This cooperative action can decrease the required dose by 4- to 16-fold in vitro.^[37] Biofilm formation represents a critical bacterial adaptation that dramatically elevates MBC, often by 10- to 1000-fold compared to planktonic cells. In chronic infections like those in cystic fibrosis, P. aeruginosa biofilms in the lung mucus create a protective matrix that limits antibiotic penetration and induces tolerance mechanisms, resulting in MBCs up to 1000 times higher than for free-floating bacteria.^[38] This heightened resistance persists due to slow-growing persister cells and extracellular polymeric substances within the biofilm.^[39]

Challenges in Measurement and Use

Determining the minimum bactericidal concentration (MBC) presents several technical challenges that limit its reliability and practicality in laboratory settings. The standard procedure, which involves subculturing from minimum inhibitory concentration (MIC) broth dilutions onto agar plates and incubating for an additional 18-24 hours, typically requires a total of 24-48 hours, making it labor-intensive and delaying results compared to MIC testing alone.^[40]^[41] Furthermore, MBC assays exhibit poor inter-laboratory reproducibility, particularly for fastidious organisms that are difficult to culture consistently, due to variations in inoculum preparation, incubation conditions, and endpoint interpretation. Endpoint ambiguity arises from the 99.9% killing criterion, as partial bacterial survival or regrowth on subculture plates can lead to subjective assessments of bactericidal activity versus bacteriostasis.^[11] In clinical contexts, MBC testing is infrequently performed due to its high cost, extended turnaround time, and the predominance of MIC-based susceptibility reporting in routine antimicrobial stewardship.^[42] Over-reliance on MIC values often overlooks the distinction between bacteriostatic and bactericidal effects, potentially underestimating the risk of treatment failure in scenarios requiring rapid bacterial eradication, such as endocarditis.^[29] Additionally, the emergence of antibiotic-tolerant subpopulations or resistance mechanisms can skew MBC values, complicating accurate prediction of in vivo efficacy and contributing to suboptimal therapeutic decisions in outpatient settings. Regulatory and standardization efforts further hinder MBC adoption, as guidelines from the Clinical and Laboratory Standards Institute (CLSI) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST) primarily emphasize MIC determination with detailed breakpoints, while MBC protocols remain optional and less harmonized.^[43] Differences in broth microdilution techniques and quality control strains between CLSI and EUCAST can result in variable MBC outcomes, exacerbating reproducibility issues.^[44] Moreover, the lack of established clinical breakpoints for MBC—especially for novel antimicrobials—limits its interpretive value, as thresholds for susceptibility are not universally defined.^[45] To address these limitations, ongoing research focuses on rapid MBC assays that reduce time to results while improving accuracy. Flow cytometry-based methods, which detect bacterial viability through fluorescent staining in as little as 7 hours, offer a promising alternative to traditional culturing by quantifying live/dead cells directly.^[46] Similarly, bioluminescence assays using molecular probes like lux reporter genes enable real-time monitoring of bacterial killing, bypassing prolonged incubation and enhancing throughput for high-volume testing.^[47] These innovations hold potential to integrate MBC data more routinely into clinical workflows, though further validation across diverse pathogens is needed.

References

[1]
Minimum Bactericidal Concentration (MBC) Test
What Is The Minimum Bactericidal Concentration (MBC) Test The MBC test determines the lowest concentration at which an antimicrobial agent will kill a parti ...
[2]
Minimum Bactericidal Concentration - an overview - ScienceDirect
MBC is the minimal antibacterial density necessary to kill bacteria, that is, bactericidal as opposed to merely bacteriostatic densities.
[3]
Establishing the Minimal Bactericidal Concentration of an ... - NIH
Jan 2, 2014 · The MBC-B is defined as the lowest concentration of antimicrobial agent that kills the cells in the biofilm. Keywords: Immunology, Issue 83, ...
[4]
Determination of minimum inhibitory concentrations - PubMed
Minimum inhibitory concentrations (MICs) are defined as the lowest concentration of an antimicrobial that will inhibit the visible growth of a microorganism ...
[5]
[PDF] Methods for Determining Bactericidal Activity of Antimicrobial Agents
Sep 4, 1999 · The techniques described in this document are intended primarily for testing aerobic bacteria that grow after incubation in adjusted Mueller- ...
[6]
DM Lab 09 - LSU School of Medicine
The MBC is identified as the smallest concentration of antibiotic that prevents any growth of the test bacterium (i.e., kills). The clinician uses the MIC and ...Missing: minimum | Show results with:minimum<|control11|><|separator|>
[7]
Methods | Emory University | Atlanta GA
Broth Microdilution MBC determination : The minimum bactericidal concentration (MBC) is the lowest concentration of an antibacterial agent required to kill ...
[8]
13.5A: Minimal Inhibitory Concentration (MIC) - Biology LibreTexts
Nov 23, 2024 · Minimum inhibitory concentration (MIC) is the lowest concentration of an antimicrobial (like an antifungal, antibiotic or bacteriostatic) drug that will ...
[9]
Busting the Myth of “Static vs Cidal”: A Systemic Literature Review
The formal definition of a bactericidal antibiotic is one for which the ratio of MBC-to-MIC is ≤4, while a bacteriostatic agent has an MBC-to-MIC ratio of >4 [1] ...
[10]
Pharmacokinetic and pharmacodynamic studies of injectable ...
Sep 1, 2025 · ... bactericidal activity (MBC50 = 4–16 × MIC). Murine systemic and localized infection models showed superior efficacy (ED50: 0.64–1.96 mg/kg ...Missing: bacteriostatic | Show results with:bacteriostatic
[11]
Bactericidal Activity, Absence of Serum Effect, and Time-Kill Kinetics ...
The MBC/MIC ratio was ≤2 against the majority (97%) of isolates tested (the MBC/MIC ratio was 4 against the one S. marcescens isolate tested). On the basis ...
[12]
Antipropionibacterial Activity of BAL19403, a Novel Macrolide ... - NIH
The time-kill profiles and MBC/MIC ratios confirmed the bacteriostatic action of BAL19403, as well as of those of erythromycin, clindamycin, and tetracycline ( ...
[13]
Combining diagnostic methods for antimicrobial susceptibility testing
The authors suggest that combining MIC and MBC determinations will provide more detailed understanding of the bacteria susceptibility to antibiotic drugs.
[14]
https://pmc.ncbi.nlm.nih.gov/articles/PMC10799838/
[15]
The Minimum Inhibitory Concentration of Antibiotics: Methods ... - NIH
Feb 4, 2021 · Minimal inhibitory concentration (MIC) defines in vitro levels of susceptibility or resistance of specific bacterial strains to applied antibiotic.
[16]
In vitro antibacterial and anti-biofilm potential of an endophytic ... - NIH
Jan 20, 2024 · If the determined MBC/MIC is > 4, the antimicrobial compound is considered bacteriostatic, whereas if the compound shows MBC/MIC ≤ 4 then it may ...
[17]
Synthesis and investigation of antimicrobial activities of ... - NIH
May 26, 2017 · The MBC/MIC or MFC/MIC ratios were used to determine bactericidal/fungicidal (MBC/MIC ≤ 4, MFC/MIC ≤ 4) or bacteriostatic/fungistatic (MBC/MIC > ...
[18]
Pharmacologic Management of Mycobacterium chimaera Infections
In addition, the corresponding MBC/MIC ratios are >4, resulting in a bacteriostatic rather than bactericidal effect when tested against these slow-growing NTMs ...
[19]
Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal ...
The aims of this study were: (1) to determine the minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) for nine antibiotics ...
[20]
https://onlinelibrary.wiley.com/doi/pdf/10.1128/9781555818814.ch5.14.1
[21]
Rapid Detection of Escherichia coli Antibiotic Susceptibility Using ...
Apr 26, 2021 · ... (MBC) [3]. An increase in the MBC can be observed for bacteria where a sub-population exhibits tolerance or persistence to an antibiotic ...<|separator|>
[22]
5.14.1 Minimum Bactericidal Concentration Testing
The minimum bactericidal concentration (MBC) test can be used to assess the abil- ity of an antimicrobial agent to kill a bac- terial isolate.
[23]
Bactericidal activity of oxacillin against beta-lactamase ...
When MBC testing was performed with salt-supplemented MHB, the oxacillin MBC/MIC ratio was greater than 8 for 17 and 16 of 17 S. aureus isolates at 30 and 35 ...
[24]
Determinations of minimum bactericidal concentrations, kill curves ...
Preliminary results suggest that the Etest provides an alternative method for studies determining the MBCs, KCs, and PAEs of various antimicrobial agents. MeSH ...
[25]
Aminoglycosides - StatPearls - NCBI Bookshelf
Jul 17, 2023 · Aminoglycosides have a broad spectrum of activity covering aerobic organisms, including gram-negative bacteria and mycobacteria.Missing: MBC | Show results with:MBC
[26]
A Pharmacodynamic Study of Aminoglycosides against Pathogenic ...
Dec 24, 2023 · It is widely accepted that an antibiotic with an MBC/MIC ratio of 4 or less is generally considered bactericidal against a particular ...
[27]
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy ...
Minimum inhibitory concentration is ≤0.12 μg/mL. The subdivisions differ from Clinical and Laboratory Standards Institute–recommended break points that are used ...
[28]
Clinical significance of tolerant strains of streptococci in adults with ...
Tolerance was defined as an MBC/MIC ratio of ≥32. Patients were followed for six months after diagnosis. The characteristics of the patients infected with ...
[29]
Serum bactericidal titres for monitoring antimicrobial therapy
There is also uncertainty whether recently approved antibiotics with activity against MDR Gram-negative pathogens such as ceftazidime–avibactam, ceftolozane– ...<|control11|><|separator|>
[30]
Bacteriostatic versus bactericidal antibiotics for patients with serious ...
Sep 28, 2014 · The categorization of antibiotics into bacteriostatic and bactericidal is unlikely to be relevant in clinical practice if used for abdominal infections.
[31]
Clinical Relevance of Bacteriostatic versus Bactericidal Mechanisms ...
Bacteriostatic activity has been defined as a ratio of MBC to MIC of >4, but ... Subinhibitory concentrations of antibiotics alter fibronectin binding ...
[32]
Role of Efflux Pumps on Antimicrobial Resistance in Pseudomonas ...
Dec 13, 2022 · Four main sets of efflux pumps have been associated with antibiotic resistance: MexAB-OprM, MexXY, MexCD-OprJ, and MexEF-OprN.
[33]
The role of multidrug efflux pumps in the antibiotic ... - PubMed
Recent research indicates that efflux pumps play a prominent role in the multidrug resistance of Pseudomonas aeruginosa and many other gram-negative bacteria.<|separator|>
[34]
Inoculum effect of β-lactam antibiotics - PMC - NIH
High-inoculum infections more rapidly reach stationary phase, thus diminishing the effect of antibiotics targeting penicillin-binding proteins, such as the β- ...
[35]
The inoculum effect and band‐pass bacterial response to periodic ...
Oct 9, 2012 · The inoculum effect (IE) refers to the decreasing efficacy of an antibiotic with increasing bacterial density.
[36]
Combined effect of pH and concentration on the activities of ...
Jan 12, 2007 · An acid environment is known to impair the activity of many antibiotics. For macrolides and aminoglycosides, lowering the pH markedly increases ...
[37]
Antibiotic efficacy is linked to bacterial cellular respiration - PNAS
We found a leftward shift in the gentamicin minimum bactericidal concentration (MBC) curve, consistent with a likely increase in drug uptake due to elevated ...<|control11|><|separator|>
[38]
Protein Binding in Translational Antimicrobial Development-Focus ...
Therefore, PPB may lead to lower concentrations of free antibiotics in the target tissue, which could reduce antimicrobial activity. This effect is enhanced for ...Missing: MBC | Show results with:MBC
[39]
In-Vitro Efficacy of Synergistic Antibiotic Combinations in Multidrug ...
Dec 29, 2009 · Beta lactam-aminoglycoside combinations were shown to be the most effective combinations against P. aeruginosa.
[40]
Lactams and Aminoglycosides, Alone and in Combination, Against ...
b Concentrations at which 50 or 90%oof the organisms were inhibited (MIC) or killed (MBC). both antibiotics; addition, a twofold reduction in the. MIC of either ...
[41]
Differences in biofilm formation and antimicrobial resistance of ... - NIH
Biofilms have been shown to be up to 1000 times more resistant to antibiotics than planktonic, or free-swimming, cells of the same isolate [2]. This is due ...Missing: MBC | Show results with:MBC
[42]
Antimicrobial resistance of Pseudomonas aeruginosa biofilms
Bacteria living in biofilms can be up to 1000 times more resistant to antibacterial compounds than planktonic bacteria [1], indicating that some of the ...
[43]
The minimum bactericidal concentration of antibiotics - BMG Labtech
Sep 18, 2024 · The minimum bactericidal concentration (MBC) is the lowest concentration of an antibiotic (expressed in mg/L) that under defined in vitro conditions reduces by ...
[44]
Minimum Inhibitory (MIC) and Minimum Bactericidal Concentration ...
The broth dilutions are streaked onto agar surface and incubated for 24 to 48 hours. MBC is the lowest broth dilution of antimicrobial that prevents the growth ...Missing: consuming | Show results with:consuming
[45]
Determination of minimum inhibitory concentrations - Oxford Academic
MBC determinations are undertaken less frequently and their major use has been reserved for isolates from the blood of patients with endocarditis. Standardized ...Missing: challenges | Show results with:challenges
[46]
EUCAST: EUCAST - Home
EUCAST develops antimicrobial susceptibility testing methodology, interpretative criteria and guidance documents to aid clinical decision making when treating ...Clinical breakpoints · MIC Determination · About EUCAST · EUCAST Statutes
[47]
Comparison of Clinical Laboratory Standards Institute and European ...
Apr 11, 2016 · The results show comparable antibiotic susceptibility patterns between CLSI and EUCAST breakpoints. Given that EUCAST guidelines are freely available,
[48]
Clinical Breakpoint Tables - EUCAST
Dec 1, 2021 · Breakpoints are part of a system for categorizing microorganisms as: Susceptible (S). Susceptible, increased exposure (I). Resistant (R). To ...EUCAST: News · Setting Breakpoints · Search · About Clinical Breakpoints
[49]
A Rapid and Quantitative Flow Cytometry Method for the Analysis of ...
Mar 17, 2016 · Screening AMP analogues using MIC/MBC growth assays takes at least 2 days, whereas the flow cytometry method can be completed in only 7 hr.Missing: probes | Show results with:probes
[50]
Rapid method for detection of minimal bactericidal concentration of ...
We developed a test for rapid determination of the minimal bactericidal concentration (MBC) of antibiotics. MBC is determined by calculating the relative ...